Assertio Holdings, Inc. (ASRT) Price Chart

This daily price chart for Assertio Holdings, Inc. (ASRT), where the metric stands at 23.49, illustrates the quotes of the developer of digital treatments for nervous system disorders with a focus on IT analytics. Under the leadership of Heather Mason, the business has overcome the restructuring phase, regaining investor confidence. Growth is driven by synergy with Spectrum Pharmaceuticals and the successful promotion of the drugs Rolvedon and Indocin.

Price Performance Chart: Assertio (ASRT) for 07/04/2022 - 06/27/2026

Assertio Holdings, Inc. (ASRT) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price assertiotx.com|ASRT - Analyst Consensus Forecast

- market capitalization details:

Market Value Assertio Holdings, Inc.|ASRT - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share Assertio|ASRT - Accounting Value of Company|Market Cap to Net Assets Ratio assertiotx.com|ASRT - Aggregate Business Assets

- debt and liquidity details:

- company profitability and valuation multiples indicators:

ASRT - Company Net Income|Projected Future Earnings Assertio Holdings, Inc.|ASRT - P/E Multiple|Future Price to Earnings Assertio Therapeutics|ASRT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Assertio Holdings, Inc.|ASRT - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Assertio|ASRT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months assertiotx.com|ASRT - Earnings per share increase in current year|Expected earnings per share growth for next year Assertio Holdings, Inc.

- sales volume and revenue information:

ASRT - Company Total Sales|Projected Sales Volume Assertio Therapeutics|ASRT - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Assertio Holdings

Analysis of all company metrics:Assertio Holdings ASRT

Signature product of Assertio Therapeutics

The monetization efficiency of the pain management drug portfolio and digital physician outreach directly determine the market value of Assertio Holdings, Inc. (ASRT). This price chart visualizes the capitalization per share, reflecting liquidity and investor reaction to pharmaceutical brand optimization through daily price action, which allows for the identification of market anomalies regardless of local price extremes.

Analysis of competing companies